Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-12-03Clinical Trial Update: Incidence and Predictors of Delirium After Cardiac Surgery
Completed study assessing the incidence and predictors of delirium after cardiac surgery, with data collected on delirium, depression, and c…
-
CLINICAL_TRIALS trial_result · 2008-12-01Clinical Trial Update: The Effect of Duloxetine on Interoceptive Awareness
This document reports an update on a clinical trial studying the effect of duloxetine on interoceptive awareness in major depressive disorde…
-
FDA approval · 2008-11-26FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for a generic Bupropion Hydrochloride product from Amneal Pharmaceuticals of New York LLC, enabling …
-
CLINICAL_TRIALS trial_result · 2008-11-26Clinical Trial Update: Pharmacy Interventions to Improve Chronic Disease Medication Refill [Phase 3]
Phase 3 clinical trial evaluating pharmacy interventions to improve chronic disease medication refills has completed.
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: Reducing Depression in Dementia Caregivers [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial aimed at reducing depression in dementia caregivers has completed. Results were posted in 2008.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-11-18Clinical Trial Update: Receptive Music Therapy for the Treatment of Depression [NA]
A completed clinical trial at Heidelberg University evaluating receptive music therapy as a treatment for depression. The update does not re…
-
CLINICAL_TRIALS trial_result · 2008-11-03Clinical Trial Update: A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD) [Phase 2]
This Phase 2 trial evaluated the combination of Elzasonan with sertraline (Zoloft) versus sertraline alone or placebo in adults with major d…
-
FDA approval · 2008-10-31FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved Apotex Corp's supplemental application for paroxetine hydrochloride (paroxetine HCl), confirming continued approval for the gen…
-
FDA approval · 2008-10-31FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved an original generic application for sertraline hydrochloride by Rising Pharma Holdings, Inc., allowing a generic version of…
-
CLINICAL_TRIALS trial_result · 2008-10-28Clinical Trial Update: Self-Management Program for Persons With Limb Loss [NA]
This is a completed clinical trial update for a self-management program designed for individuals with limb loss, addressing conditions such …
-
FDA approval · 2008-10-22FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., indicating a modification to the product's a…
-
CLINICAL_TRIALS trial_result · 2008-10-17Clinical Trial Update: Nexalin Therapy for the Treatment of Depressive Symptoms [Phase 2]
A Phase 2 clinical trial evaluating Nexalin Therapy for depressive symptoms has been completed.
-
CLINICAL_TRIALS research · 2008-10-17Clinical Trial Update: Dose Milnacipran Prevent Depressive Symptoms in Patients With Acute Stroke? [NA]
Update on a clinical trial testing whether milnacipran can prevent depressive symptoms in patients with acute ischemic stroke; the trial sta…
-
FDA approval · 2008-10-11FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Lexapro (escitalopram) submitted by Allergan, authorizing changes to the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2008-10-10Clinical Trial Update: Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group [Phase 2]
A Phase 2 clinical trial conducted by UCLA investigators studied antidepressant treatment in Mexican-Americans with major depressive disorde…
-
CLINICAL_TRIALS trial_result · 2008-10-09Clinical Trial Update: Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression [Phase 4]
Phase 4 study assessing the safety and efficacy of venlafaxine XR in elderly patients with major depressive disorder.
-
FDA approval · 2008-09-25FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for Fluoxetine hydrochloride from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: Acupuncture and Massage for Depression During Pregnancy [Phase 2]
Phase 2 clinical trial update documenting the completion of a study evaluating acupuncture and massage for depression during pregnancy, spon…
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: Electroencephalography (EEG) Biomarkers of Response in Depression [Phase 4]
This update reports on a Phase 4 trial evaluating EEG biomarkers of response in Major Depressive Disorder. The study has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-22Clinical Trial Update: Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression
This completed clinical trial update from NIMH investigates treatment-emergent suicidal ideation in patients with major depressive disorder,…
-
FDA approval · 2008-09-18FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Celexa (citalopram) filed by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2008-09-18Clinical Trial Update: Aripiprazole as Augmentation for TRD [Phase 2]
Phase 2 trial evaluating aripiprazole as augmentation for treatment-resistant depression has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-01Clinical Trial Update: Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression [Phase 2]
Phase 2 clinical trial investigating patient dimensions as predictors of varied treatment responses and outcomes in major depressive disorde…
-
CLINICAL_TRIALS trial_result · 2008-09-01Clinical Trial Update: Stress Generation and Recurrent Depression: The Role of Differential Treatment Response [Phase 1]
This Phase 1 clinical trial update investigates how stress generation relates to recurrent depression and how differential treatment respons…
-
CLINICAL_TRIALS trial_result · 2008-08-26Clinical Trial Update: Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder [NA]
A completed clinical trial evaluating the effects of risperidone and olanzapine in patients with schizophrenia, schizoaffective disorder, ma…